Budesonide, Glycopyrronium Bromide and Formoterol Fumarate Inhalation Aerosol.

Budeglobulin inhalation aerosol for maintenance treatment of patients with chronic obstructive pulmonary disease

Budeglobose inhalation aerosol adopts innovative co-suspension delivery technology to jointly deliver three drug ingredients: budesonide (inhaled corticosteroid ICS)/glycopyrrolate (long-acting anticholinergic drug LAMA)/formoterol fumarate (long-acting β2 receptor agonist LABA), providing an important treatment option for patients with stable COPD.